SEC Comment Letter 0000000000-24-004107 to Merus N.V. (MRUS) (CIK 0001651311)
Merus N.V. (MRUS) (CIK 0001651311)
Date: April 16, 2024 · CIK: 0001651311 · Accession: 0000000000-24-004107
AI Filing Summary & Sentiment
File numbers found in text: 001-37773
Letter
United States securities and exchange commission logo April 15, 2024 Gregory Perry Chief Financial Officer Merus N.V. Uppsalalaan 17 3584 CT Utrecht The Netherlands Re:Merus N.V. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-37773 Dear Gregory Perry: We have limited our review of your filings to the financial statements and related disclosures and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Form 10-K for Fiscal Year Ended December 31, 2023 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations Results of Operations for the Years Ended December 31, 2023 and 2022, page 103 1.We note the statement that you do not allocate employee-related costs, depreciation, rental and other indirect costs to specific research and development programs. Please revise future filings to disclose the costs incurred program-by-program for those costs that are tracked. Also revise to provide other quantitative disclosure that provides more transparency as to the type of research and development expenses incurred (i.e., by nature or type of expense) which should reconcile to total research and development expense on the Consolidated Statements of Operations for all periods presented. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
FirstName LastNameGregory Perry Comapany NameMerus N.V. April 15, 2024 Page 2 FirstName LastName Gregory Perry Merus N.V. April 15, 2024 Page 2 Please contact Lynn Dicker at 202-551-3616 or Eric Atallah at 202-551-3663 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
April 15, 2024
Gregory Perry
Chief Financial Officer
Merus N.V.
Uppsalalaan 17
3584 CT Utrecht
The Netherlands
Re:Merus N.V.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-37773
Dear Gregory Perry:
We have limited our review of your filings to the financial statements and related
disclosures and have the following comment.
Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this letter, we may have additional comments.
Form 10-K for Fiscal Year Ended December 31, 2023
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations for the Years Ended December 31, 2023 and 2022, page 103
1.We note the statement that you do not allocate employee-related costs, depreciation, rental
and other indirect costs to specific research and development programs. Please revise
future filings to disclose the costs incurred program-by-program for those costs that are
tracked. Also revise to provide other quantitative disclosure that provides more
transparency as to the type of research and development expenses incurred (i.e., by nature
or type of expense) which should reconcile to total research and development expense on
the Consolidated Statements of Operations for all periods presented.
In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
FirstName LastNameGregory Perry
Comapany NameMerus N.V.
April 15, 2024 Page 2
FirstName LastName
Gregory Perry
Merus N.V.
April 15, 2024
Page 2
Please contact Lynn Dicker at 202-551-3616 or Eric Atallah at 202-551-3663 with any
questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences